Atrion (NASDAQ:ATRI) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Atrion (NASDAQ:ATRI) in a research note published on Thursday. The firm issued a sell rating on the medical instruments supplier’s stock.

Atrion Stock Up 0.1 %

NASDAQ:ATRI opened at $459.92 on Thursday. Atrion has a twelve month low of $274.98 and a twelve month high of $503.24. The firm has a market capitalization of $809.46 million, a price-to-earnings ratio of 43.23 and a beta of 0.69. The stock’s 50 day moving average price is $458.99 and its two-hundred day moving average price is $445.87.

Atrion (NASDAQ:ATRI) last issued its earnings results on Thursday, August 8th. The medical instruments supplier reported $0.23 earnings per share for the quarter. The business had revenue of $48.77 million for the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%.

Institutional Trading of Atrion

Hedge funds have recently made changes to their positions in the business. Jump Financial LLC bought a new stake in Atrion in the 4th quarter valued at $234,000. Quadrant Capital Group LLC bought a new position in shares of Atrion in the fourth quarter valued at about $36,000. Penn Mutual Asset Management LLC acquired a new stake in shares of Atrion during the 4th quarter worth about $1,949,000. Principal Financial Group Inc. bought a new stake in shares of Atrion during the 1st quarter worth about $280,000. Finally, BNP Paribas Financial Markets grew its stake in Atrion by 3.6% in the 1st quarter. BNP Paribas Financial Markets now owns 723 shares of the medical instruments supplier’s stock valued at $335,000 after buying an additional 25 shares during the last quarter. 66.19% of the stock is owned by institutional investors and hedge funds.

About Atrion

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.